XML 33 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 11 - Share Based Compensation
12 Months Ended
Dec. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
11.
  SHARE BASED COMPENSATION
 
At
December 30, 2017,
the Company had
two
share-based employee compensation plans. The Company measures the fair value of share-based awards, if and when granted, based on the Black-Scholes method and using the closing market price of the Company’s common stock on the date of grant. Awards vest over periods ranging from
one
to
three
years and expire within
10
years of issuance. Share-based compensation expense related to time-based awards is amortized in accordance with applicable vesting periods using the straight-line method. The Company vests performance-based awards only when the performance metrics are likely to be achieved and the associated awards are therefore likely to vest. Performance-based share awards that are likely to vest are also expensed on a straight-line basis over the vesting period but
may
vest on a retroactive basis or be reversed, depending on when it is determined that they are likely to vest, or in the case of a reversal when they are later determined to be unlikely to vest.
 
Share-based compensation expense of $
770
and
$901
was recognized for the fiscal years ended
December 30, 2017
and
December 31, 2016,
respectively.
Share based compensation for the fiscal years ended
December 30, 2017
and
December 31, 2016
did
not
include any expense associated with performance-based awards since they were, as of
December 30, 2017
and
December 31, 2016
, determined to be unlikely to vest.
 
As of
December 30, 2017,
the Company had approximately
$0.4
million of total unrecognized compensation cost related to all time-based non-vested share-based awards granted under the Company’s various share-based plans, which the Company expects to recognize over fiscal
2017.
These amounts do
not
include a) performance-based restricted stock units, b) the cost of any additional share-based awards that
may
be granted in future periods or c) the impact of any potential changes in the Company’s forfeiture rate. During fiscal
2016,
the Company’s Compensation Committee of the Board of Directors adopted a Long Term Incentive Plan (“LTIP”) for certain executives. The LTIP is anticipated to issue restricted share units each fiscal year that are contingent upon achieving certain performance metrics as defined by the Compensation Committee over a
three
fiscal year performance period. The Company issued
200,000
such performance-based restricted share units in fiscal
2017.
As of
December 30, 2017,
these performance-based restricted share units were deemed unlikely to vest and therefore
no
expense has been recognized
.
 
2014
Omnibus Equity Compensation Plan (the
2014
Plan)
 
The
2014
Plan, approved by the Company
’s stockholders in
December 2014,
provides for the issuance of up to
625,000
shares of the Company’s common stock to officers, non-employee directors, employees of the Company and its subsidiaries or consultants and advisors utilized by the Company. The Compensation Committee of the Board of Directors determines the vesting period at the time of grant.
 
In fiscal
2016,
the Company amended the
2014
Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance under the Plan by an additional
500,000
shares so that the total number of shares of stock reserved for issuance under the Plan shall be
1,125,000
shares and to extend the expiration date of the Plan to
December 1, 2026.
 
As of
December 30, 2017,
under the
2014
Plan,
87,034
time-based and
400,000
performance-based restricted share units were outstanding and
332,232
shares were available for awards thereunder.
 
Employee Stock Purchase Plan
 
The Company implemented the
2001
Employee Stock Purchase Plan (the “Purchase Plan”) with shareholder approval, effective
January 1, 2001.
Under the Purchase Plan, employees meeting certain specific employment qualifications are eligible to participate and can purchase shares of common stock semi-annually through payroll deductions at the lower of
85%
of the fair market value of the stock at the commencement or end of the offering period. The purchase plan permits eligible employees to purchase shares of common stock through payroll deductions for up to
10%
of qualified compensation
, subject to maximum purchases in any
one
fiscal year of
3,000
shares.
 
In fiscal
2015,
the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional
300,000
shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be
1,100,000
shares and to extend the expiration date of the Plan to
December 31, 2025.
 
During the fiscal years ended
December 30, 2017
and
December 31, 2016,
there were
90,931
and
81,225
shares issued under the Purchase Plan for net proceeds of
$394
and
$368,
respectively. As of
December 30, 2017,
there were
177,280
shares available for issuance under the Purchase Plan. Compensation expense, representing the discount to the quoted market price, for the Purchase Plan for the fiscal years ended
December 30, 2017
and
December 31, 2016
was
$114
and
$108,
respectively.
 
 
Stock Option Awards
 
Transactions related to all stock options
under all plans are as follows:
 
   
All Stock Options Outstanding
 
   
 
Shares
   
Weighted Average
Exercise Price
 
Options outstanding as of
January 2, 2016
   
44,500
    $
8.12
 
Options granted
   
-
     
 
 
Options exercised, net
   
(2,500
)
  $
5.62
 
Options forfeited/cancelled
   
-
     
 
 
                 
Options outstanding as of
December 31, 2016
   
42,000
    $
8.27
 
                 
Options exercisable as of
December 31, 2016
   
27,000
    $
9.47
 
                 
Intrinsic value of outstanding stock options as of
December 31, 2016
  $
6
     
 
 
                 
Intrinsic value of stock options exercised in fiscal year ended
December 31, 2016
  $
3
     
 
 
                 
Weighted average grant date fair value of stock options issued during fiscal year ended
December 31, 2016
   
N/A
     
 
 
                 
Options outstanding as of
December 31, 2016
   
42,000
    $
8.27
 
Options granted
   
-
     
 
 
Options exercised, net
   
(11,917
)
  $
6.00
 
Options forfeited in cashless exercises    
(5,083
)   $
6.10
 
Options forfeited/cancelled
   
(25,000
)
  $
9.81
 
                 
Options outstanding as of
December 30, 2017
   
-
     
 
 
                 
Options exercisable as of
December 30, 2017
   
-
     
 
 
                 
Intrinsic value of outstanding stock options as of
December 30, 2017
   
-
     
 
 
                 
Intrinsic value of stock options exercised in fiscal year ended
December 30, 2017
   
17
     
 
 
                 
Weighted average grant date fair value of stock options issued during fiscal year ended
December 30, 2017
   
-
     
 
 
 
Stock Option Awards (Continued)
 
A summary of the status of our nonvested stock options outstanding as of
December 30, 2017,
and changes during the year then ended is presented as follows:
 
 
 
Nonvested Stock Options
 
 
 
Shares
   
Weigh
ted-Average
Grant-Date
Fair Value
 
Nonvested at
December 31, 2016
   
15,000
    $
2.33
 
Vested
   
15,000
    $
2.33
 
Forfeited
   
-
     
-
 
Issued nonvested
   
-
     
-
 
Nonvested at
December 30, 2017
   
-
     
-
 
 
Time-Based Restricted Stock Units
 
From time-to-time
the Company issues time-based restricted stock units. These time-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee’s restricted stock unit fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. Dividends for time-based restricted stock units that ultimately do
not
vest are forfeited.
 
To date, the Company has only issued
time-based restricted stock units under the
2007
and
2014
Plans. The following summarizes the activity in the time-based restricted stock units under the
2007
and
2014
Plans during the
fifty-two
week period ended
December 30, 2017:
 
   
Number of
Time-Based
Restricted
Stock Units
   
Weighted
Average
Grant Date Fair
Value per Share
 
Outstanding non-vested at December 31, 2016
   
197,734
    $
7.33
 
Granted
   
87,034
    $
5.88
 
Vested
   
(197,734
)
  $
7.33
 
Forfeited or expired
   
-
     
-
 
Outstanding non-vested at
December 30, 2017
   
87,034
    $
5.88
 
 
Based on the closing price of the Company
’s common stock of
$6.25
per share on
December 29, 2017 (
the last trading day prior to
December 30, 2017),
the intrinsic value of the time-based non-vested restricted stock units at
December 30, 2017
was approximately
$0.5
million. As of
December 30, 2017,
there was approximately
$0.4
million of total unrecognized compensation cost related to time-based restricted stock units, which is expected to be recognized over the vesting period of the restricted stock units.
 
Performance Based Restricted Stock Units
 
From time-to-time the Company issues performance-based restricted stock units to its executives.
  Performance-based restricted stock units are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. These performance-based restricted stock units typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock units that actually vest, if any.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet.  Dividends for performance-based restricted stock units that ultimately do
not
vest are forfeited.   
 
To date, the Company has only issued performance-based restricted stock units under
the
2014
Plan.  The following summarizes the activity in the performance-based restricted stock units during
2017:
 
   
Number of
Performance-
Based
Restricted
Stock Units
   
 
Weighted
Average
Grant Date Fair
Value per Share
 
Outstanding non-vested at
December 31, 2016
   
200,000
    $
5.36
 
Granted
   
200,000
    $
4.85
 
Vested
   
-
     
-
 
Forfeited or expired
   
-
     
-
 
Outstanding non-vested at
December 30, 2017
   
400,000
    $
5.11
 
 
As of
December 30, 2017,
the Company considers the metrics related to
400,000
of the performance-based restricted stock units unlikely to be achieved, thus
no
performance condition is probable of achievement and
no
compensation cost has been recognized on the performance-based restricted stock units. The Company will reassess at each reporting date whether achievement of any performance condition is probable and would begin recognizing compensation cost if and when achievement of the performance condition becomes probable. The Company will then recognize the appropriate expense cumulatively in the year performance becomes probable and recognize the remaining compensation cost over the remaining requisite service period.
 
   
Number of
Restricted
Stock Units
(in thousands)
   
 
Weighted Average
Grant Date Fair
Value per Share
 
Outstanding non-vested at
January 2, 2016
   
209
    $
7.10
 
Granted
– time-based vesting
   
63
    $
5.98
 
Granted
– performance-based vesting
   
200
    $
5.36
 
Vested
   
(74
)
  $
5.56
 
Forfeited or expired
   
-
     
-
 
Outstanding non-vested at
December 31, 2016
   
398
    $
6.34
 
Granted
– time-based vesting
   
87
    $
5.88
 
Granted
– performance-based vesting
   
200
    $
4.85
 
Vested
   
(198
)
  $
7.33
 
Forfeited or expired
   
-
     
-
 
Outstanding non-vested at
December 30, 2017
   
487
    $
5.24
 
 
Based on the closing price of the Company
’s common stock of
$6.25
per share on
December 29, 2017,
the intrinsic value of the non-vested time-based restricted share units at
December 30, 2017
was
$0.5
million. This amount does
not
include any intrinsic value that
may
be associated with the performance-based restricted share units that are deemed unlikely to vest.